跳至主要内容
临床试验/NCT02490124
NCT02490124已完成不适用

The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans

University of Virginia1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
7
试验地点
1
主要终点
Pulse Wave Velocity

研究概览

简要总结

Arterial vascular disease is the major cause of morbidity and mortality for Type 1 diabetic patients (DM1). Metabolic insulin resistance (metIR), even in the absence of hyperglycemia, conveys a 1.5 to 3-fold increased CVD risk in the general population. Metabolic Insulin Resistance (MetIR) has been repeatedly shown to be prevalent in adults and adolescents with DM1. MetIR in obesity and DM2 are accompanied by vascular insulin resistance (vasIR) which is characterized by impaired vasodilatory action of insulin on resistance or microvascular vessels. VasIR has not been systematically studied in DM1. We hypothesize that in young adults DM1 impairs both baseline and insulin-responsive vascular function throughout the arterial vasculature.

详细描述

In our study, 20 healthy control subjects will be compared to 20 DM1 patients (18-40 yrs). We will assess function in conduit (pulse wave velocity-PWV, flow-mediated dilation-FMD and augmentation index-AI), resistance (post-ischemic flow velocity-PIFV) and heart and skeletal muscle microvascular (contrast enhanced ultrasound-CEU) vessels before and after 2 hrs of a euglycemic insulin clamp.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-40
  • Healthy with no chronic illness (control group only)
  • Normal screening labs or no clinically significant values
  • DM1 subjects will have been on insulin for at least 5 years and HbA1c <9

排除标准

  • First degree relative with Type 1 or 2 Diabetes (for control group only)
  • Smoking presently or in the past 6 months
  • Medications that affect the vasculature (except ACE or ARB in DM1 subjects, although they will need to be off these drugs for 2 weeks prior to study).
  • Elevated LDL cholesterol > 160
  • BP <100/60 or >160/90
  • Pulse oximetry <90%
  • Pregnant or breastfeeding
  • History of cardiovascular disease, cerebral vascular disease, peripheral vascular disease, liver disease
  • Presence of an intracardiac or intrapulmonary shunt (we will screen for this by auscultation during the physical exam ).
  • Known hypersensitivity to perflutren (contained in Definity)
  • For DM1 group:
  • HbA1c ≥ 9
  • Microalbuminuria
  • Retinipathy
  • Ketoacidosis within the past year.

结局指标

主要结局

Pulse Wave Velocity

时间窗: after 2 hour insulin clamp

vascular measure

Flow Mediated Dilation

时间窗: after 2 hour insulin clamp

vascular measure

Augmentation Index

时间窗: after 2 hour insulin clamp

vascular measure

Contrast Enhanced Ultrasound

时间窗: after 2 hour insulin clamp

vascular measure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eugene Barrett

Professor Eugene Barrett MD PhD

University of Virginia

研究点 (1)

Loading locations...

相似试验

The Effect of Type 1 Diabetes on Pan-Arterial... | 临床试验